Tag: vote

VALLOUREC
Société anonyme à Conseil d’Administration
au capital de 4 767 162,72 €
Siège social : 12, rue de la Verrerie – 92190 Meudon
552 142 200 RCS Nanterre

CHARLOTTE, N.C. and STAMFORD, Conn., July 18, 2025 (GLOBE NEWSWIRE) -- HCM II Acquisition Corp., (Nasdaq: HOND), (“HCM II”), a special-purpose acquisition company and Terrestrial Energy Inc., (“Terrestrial Energy”), a developer of small modular nuclear plants using advanced reactor technology, today announced the filing of the draft registration statement on Form S-4 with the U.S. Securities and Exchange Commission (“SEC”).

EDISON, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) ("Eos" or the “Company”), an American energy company and the leading innovator in designing, sourcing, manufacturing, and providing zinc-based battery energy storage systems (BESS) manufactured in the United States, today announced it will release its second quarter 2025 financial results after the U.S. market closes on July 30, 2025. A conference call to discuss its results will take place the following morning on July 31, 2025, at 8:30 a.m. Eastern Time.

TORONTO, July 16, 2025 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB) (“RWB” or the “Company”) announces that its 2025 Annual General Meeting of Shareholders (the “AGM”), which was originally convened and subsequently adjourned on July 11, 2025, will reconvene on August 8, 2025 at 8:00 a.m. (Pacific Time), at Suite 1890 – 1075 West Georgia Street, Vancouver, British Columbia, and by teleconference at 1-877-407-8816, Participation Code: 77783, followed by the # key. The reconvened meeting is being held in accordance with the Articles of the Company.

Revised Potential Distribution Range of $0.03 to $0.07 per share
based on current estimates and assumptions

NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group," “Aptorum” or the "Company"), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs in oncology  and infectious diseases, and DiamiR Biosciences (“DiamiR”), a developer of proprietary innovative blood-based tests for brain health and other diseases with a CLIA licensed, CAP accredited clinical laboratory in New Haven, CT, today announced that they have entered into a definitive agreement for an all-stock merger transaction, in which DiamiR Biosciences will retain its name and become a wholly-owned subsidiary of Aptorum Group upon consummation of the merger.The combined company expects to remain listed on the Nasdaq Stock Market following the closing of the merger.

DALLAS, July 15, 2025 (GLOBE NEWSWIRE) -- Veritex Holdings, Inc. (Nasdaq: VBTX), the parent holding company for Veritex Community Bank, today announced a date change for release of its second quarter 2025 earnings results. Veritex will now release its second quarter 2025 earnings results before the opening of the market on Friday, July 18, 2025. The earnings release will be available on Veritex’s website, https://ir.veritexbank.com/.